Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL
Brydon Panozzo, Matthew Rubic, Jian Li, Catelyn Cashion et autres
au (code pays fourni par la source)
0 citations
Blood Advances